Home › Focal Segmental Glomerulosclerosis › California › San Francisco
Focal Segmental Glomerulosclerosis clinical trials in San Francisco, CA
3 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Kaiser Permanente - French Campus, San Francisco
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Miami, FL6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Queens, NY6 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Dallas, TX4 studies
- Cleveland, OH4 studies
- Kansas City, MO4 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Ovarian Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.